0.6459
price up icon0.17%   0.0011
after-market 시간 외 거래: .64 -0.0059 -0.91%
loading

Scynexis Inc 주식(SCYX)의 최신 뉴스

pulisher
Dec 08, 2025

SCYNEXIS (NASDAQ:SCYX) versus NewAmsterdam Pharma (NASDAQ:NAMS) Head to Head Analysis - Defense World

Dec 08, 2025
pulisher
Dec 06, 2025

Can SCYNEXIS Stock Hold Up When Markets Turn? - Trefis

Dec 06, 2025
pulisher
Dec 05, 2025

Can SCYNEXIS Inc. stock surprise with earnings upsideVolume Spike & Real-Time Price Movement Reports - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why SCYNEXIS Inc. (135A) stock stays resilientWeekly Stock Report & Smart Swing Trading Techniques - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

How SCYNEXIS Inc. stock trades before earnings2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

SCYNEXIS (NASDAQ:SCYX) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World

Dec 04, 2025
pulisher
Dec 03, 2025

What is the fair value of SCYNEXIS Inc. stock nowEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - Newser

Dec 03, 2025
pulisher
Dec 03, 2025

Is SCYNEXIS Inc. (135A) stock considered safe havenDollar Strength & Low Risk Investment Opportunities - Newser

Dec 03, 2025
pulisher
Nov 30, 2025

Free cash flow per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Nov 30, 2025
pulisher
Nov 30, 2025

Working capital per share of SCYNEXIS, Inc. – LSE:0L49 - TradingView

Nov 30, 2025
pulisher
Nov 29, 2025

Macro Review: Why SCYNEXIS Inc. stock is trending among retail tradersJuly 2025 Retail & Risk Adjusted Buy and Sell Alerts - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Why SCYNEXIS Inc. stock is a must watch in 2025Portfolio Gains Report & Community Verified Swing Trade Signals - moha.gov.vn

Nov 28, 2025
pulisher
Nov 28, 2025

Why SCYNEXIS Inc. (135A) stock is listed among top recommendationsQuarterly Portfolio Review & Risk Managed Investment Entry Signals - BỘ NỘI VỤ

Nov 28, 2025
pulisher
Nov 27, 2025

Is SCYNEXIS Inc a good long term investmentGrowth Stock Opportunities & Exceptional Return Growth - earlytimes.in

Nov 27, 2025
pulisher
Nov 26, 2025

Is SCYNEXIS Inc. stock trading at a premium valuation2025 Short Interest & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ

Nov 26, 2025
pulisher
Nov 25, 2025

It is Poised to be a Bull Market for Scynexis Inc (SCYX) - Setenews

Nov 25, 2025
pulisher
Nov 25, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Nov 25, 2025
pulisher
Nov 20, 2025

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

Nov 20, 2025
pulisher
Nov 20, 2025

Investors in cash trouble should check out Scynexis Inc (SCYX) - Setenews

Nov 20, 2025
pulisher
Nov 20, 2025

Will SCYNEXIS Inc. (135A) stock outperform foreign stocksJuly 2025 Action & Risk Managed Trade Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Scynexis announces grant for Hackensack Meridian, Johns Hopkins collaboration - MSN

Nov 20, 2025
pulisher
Nov 20, 2025

Analyzing recovery setups for SCYNEXIS Inc. investorsFed Meeting & Fast Gain Stock Trading Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Will SCYNEXIS Inc. stock recover faster than peersJuly 2025 Update & Technical Pattern Alert System - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis Transfers Brexafemme New Drug Application to GSK - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS, Inc. Completes Transfer of Brexafungerp New Drug Application to Gsk - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis completes transfer of Brexafemme new drug application to GSK - MarketScreener

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS Completes BREXAFEMME NDA Transfer to GSK, Positioning for Future Milestones and Royalties - Quiver Quantitative

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS Completes Transfer of BREXAFEMME® New Drug Application to GSK - The Manila Times

Nov 19, 2025
pulisher
Nov 19, 2025

Scynexis completes transfer of Brexafemme New Drug Application To GSK - TradingView

Nov 19, 2025
pulisher
Nov 19, 2025

SCYNEXIS (NASDAQ: SCYX) transfers BREXAFEMME NDA to GSK, up to $145.5M - Stock Titan

Nov 19, 2025
pulisher
Nov 19, 2025

Is SCYNEXIS Inc. stock attractive for passive investorsMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

GSK Completes Acquisition of BREXAFEMME NDA for U.S. Market Rela - GuruFocus

Nov 19, 2025
pulisher
Nov 18, 2025

How to build a dashboard for SCYNEXIS Inc. stockEarnings Overview Report & Risk Controlled Daily Trade Plans - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Scynexis fungerps among funding recipients - BioWorld MedTech

Nov 18, 2025
pulisher
Nov 17, 2025

SCYNEXIS receives $7 million annual grant for antifungal research By Investing.com - Investing.com Nigeria

Nov 17, 2025
pulisher
Nov 17, 2025

SCYX Secures Federal Grant for Antifungal Research - GuruFocus

Nov 17, 2025
pulisher
Nov 17, 2025

Scynexis Announces Federal Funding of Collaboration Between Hackensack Meridian CDI and Johns Hopkins Researchers to Develop New Therapeutics, Including Novel Fungerps, for Resistant Fungal Infections - The Manila Times

Nov 17, 2025
pulisher
Nov 17, 2025

SCYNEXIS Receives $35 Million NIH Grant to Develop Next-Generation Antifungal Therapies - Quiver Quantitative

Nov 17, 2025
pulisher
Nov 17, 2025

Scynexis (NASDAQ: SCYX) fungerps program included in $7M NIH CETR grant - Stock Titan

Nov 17, 2025
pulisher
Nov 16, 2025

Why SCYNEXIS Inc. (135A) stock benefits from AI revolutionForecast Cut & AI Forecast Swing Trade Picks - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Live market analysis of SCYNEXIS Inc.July 2025 Recap & Community Verified Trade Signals - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

Will SCYNEXIS Inc. (135A) stock deliver stable dividendsJuly 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com

Nov 15, 2025
pulisher
Nov 15, 2025

How geopolitical tensions affect SCYNEXIS Inc. stockEarnings Recap Summary & Consistent Return Investment Signals - newser.com

Nov 15, 2025
$37.21
price down icon 1.48%
$21.29
price up icon 0.09%
drug_manufacturers_specialty_generic RDY
$14.02
price down icon 0.50%
$11.65
price up icon 0.52%
$152.80
price down icon 1.26%
$493.99
price up icon 1.12%
자본화:     |  볼륨(24시간):